Vaccines Against Influenza and Other Respiratory Virus Infections
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Influenza Virus Vaccines".
Deadline for manuscript submissions: 20 October 2025 | Viewed by 115
Special Issue Editor
Interests: virus pathogenesis; immune responses to vaccines; sex differences in immune responses; immune responses during pregnancy; impact of obesity on immune function; vaccine development; optimizing vaccine efficacy and safety
Special Issue Information
Dear Colleagues,
Respiratory viral infections represent significant global public health challenges, resulting in millions of illnesses and deaths each year. Vaccines are crucial in preventing these infections by eliciting specific immune responses, including mucosal immunity, antibody production, and T-cell responses. Despite significant advancements in vaccine development for respiratory viral infections, several challenges remain. Some of these challenges include addressing the high mutation rates of the viruses, promoting cross-protective and long-lasting immunity, ensuring effective mucosal immunity in the respiratory tract, providing adequate protection for high-risk populations, and minimizing potential adverse effects associated with the vaccines.
This Special Issue aims at highlighting recent advancements in developing and testing vaccines against influenza and other respiratory viral infections. We welcome the submission of original research and review articles which may focus on one or more of the following topics:
- Development of vaccines against respiratory viral pathogens.
- Exploration of adjuvants or vaccine delivery platforms targeting respiratory viral pathogens.
- Evaluation of mechanisms involved in vaccine-induced immune responses, such as mucosal immunity, antibody production, and T-cell responses.
- Testing the protective efficacy of vaccines against respiratory viral pathogens.
- Assessment of immunogenicity, protective efficacy, and adverse reactions of vaccines in high-risk groups, including the elderly, children, pregnant women, and immunocompromised individuals.
- Monitoring side effects, adverse reactions, and long-term safety profiles of vaccines against respiratory viral infections.
Dr. Santosh Dhakal
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- adjuvants
- influenza
- mucosal immunity
- respiratory viral pathogens
- vaccine effectiveness
- vaccine safety
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
